INCORPORATION OF INVITRO ENZYME DATA INTO THE PHYSIOLOGICALLY-BASED PHARMACOKINETIC (PB-PK) MODEL FOR METHYLENE-CHLORIDE - IMPLICATIONS FOR RISK ASSESSMENT

被引：73
|
作者：
REITZ, RH
MENDRALA, AL
PARK, CN
ANDERSEN, ME
GUENGERICH, FP
机构：
[1] USAF,ARMSTRONG AEROSP MED RES LAB,WRIGHT PATTERSON AFB,OH 45433
[2] VANDERBILT UNIV,DEPT BIOCHEM,NASHVILLE,TN 37240
来源：
TOXICOLOGY LETTERS | 1988年 / 43卷 / 1-3期
关键词：
D O I：
10.1016/0378-4274(88)90023-9
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
引用
收藏
页码：97 / 116
页数：20
相关论文
共 26 条
  • [21] A PHYSIOLOGICALLY BASED PHARMACOKINETIC AND PHARMACODYNAMIC MODEL TO DESCRIBE THE ORAL DOSING OF RATS WITH ETHYL ACRYLATE AND ITS IMPLICATIONS FOR RISK ASSESSMENT
    FREDERICK, CB
    POTTER, DW
    CHANGMATEU, MI
    ANDERSEN, ME
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 1992, 114 (02) : 246 - 260
  • [22] Development of a physiologically-based pharmacokinetic model of 2-phenoxyethanol and its metabolite phenoxyacetic acid in rats and humans to address toxicokinetic uncertainty in risk assessment
    Troutman, John A.
    Rick, David L.
    Stuard, Sharon B.
    Fisher, Jeffrey
    Bartels, Michael J.
    REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2015, 73 (02) : 530 - 543
  • [23] REDUCED PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL FOR REPAGLINIDE: IMPACT OF OATP1B1 GENOTYPE AND SOURCE OF IN VITRO DATA ON THE PREDICTION OF DRUG-DRUG INTERACTION RISK
    Gertz, Michael
    Saell, Carolina
    Houston, J. Brian
    Galetin, Aleksandra
    DRUG METABOLISM REVIEWS, 2014, 45 : 258 - 258
  • [24] Response to "letter concerning: Clewell (2019) incorporation of in vitro metabolism data and physiologically based pharmacokinetic modeling in a risk assessment for chloroprene." (UIHT-2020-0053)
    Clewell, H. J., III
    Campbell, J. L.
    Van Landingham, C.
    Franzen, A.
    Yoon, M.
    Dodd, D. E.
    Andersen, M. E.
    Gentry, P. R.
    INHALATION TOXICOLOGY, 2020, 32 (9-10) : 369 - 371
  • [25] Reduced Physiologically-Based Pharmacokinetic Model of Repaglinide: Impact of OATP1B1 and CYP2C8 Genotype and Source of In Vitro Data on the Prediction of Drug-Drug Interaction Risk
    Gertz, Michael
    Tsamandouras, Nikolaos
    Saell, Carolina
    Houston, J. Brian
    Galetin, Aleksandra
    PHARMACEUTICAL RESEARCH, 2014, 31 (09) : 2367 - 2382
  • [26] Reduced Physiologically-Based Pharmacokinetic Model of Repaglinide: Impact of OATP1B1 and CYP2C8 Genotype and Source of In Vitro Data on the Prediction of Drug-Drug Interaction Risk
    Michael Gertz
    Nikolaos Tsamandouras
    Carolina Säll
    J. Brian Houston
    Aleksandra Galetin
    Pharmaceutical Research, 2014, 31 : 2367 - 2382
123